Published in Antiviral Res on April 04, 2016
N-Desmethylclozapine, Fluoxetine and Salmeterol inhibit post-entry stages of dengue virus life-cycle. Antimicrob Agents Chemother (2016) 0.79
Human enterovirus 71 protein interaction network prompts antiviral drug repositioning. Sci Rep (2017) 0.75
Cellular fatty acid synthase is required for late stages of HIV-1 replication. Retrovirology (2017) 0.75
NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41
The global distribution and burden of dengue. Nature (2013) 27.92
Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother (2005) 7.42
Global spread and persistence of dengue. Annu Rev Microbiol (2008) 6.44
Prospects for a dengue virus vaccine. Nat Rev Microbiol (2007) 4.99
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med (2003) 4.69
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30
The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Lett (2007) 4.23
Discovery of insect and human dengue virus host factors. Nature (2009) 3.49
Defining challenges and proposing solutions for control of the virus vector Aedes aegypti. PLoS Med (2008) 3.43
A hitchhiker's guide to the human Hsp70 family. Cell Stress Chaperones (1996) 2.70
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell (2008) 2.49
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis (2007) 2.22
Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett (2007) 2.21
Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep (2010) 2.14
Strategies for development of Dengue virus inhibitors. Antiviral Res (2010) 2.11
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res (2009) 2.03
Recruitment of Hsp70 chaperones: a crucial part of viral survival strategies. Rev Physiol Biochem Pharmacol (2005) 1.95
Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Res (2005) 1.93
Ten years of dengue drug discovery: progress and prospects. Antiviral Res (2013) 1.84
Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol (2005) 1.83
Targeting heat shock proteins in cancer. Cancer Lett (2010) 1.83
Pathogenesis of flavivirus infections: using and abusing the host cell. Cell Host Microbe (2009) 1.81
Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone? Cell Cycle (2010) 1.75
Dengue vaccines: progress and challenges. Curr Opin Immunol (2011) 1.40
Dengue viruses - an overview. Infect Ecol Epidemiol (2013) 1.40
Critical issues in dengue vaccine development. Curr Opin Infect Dis (2011) 1.39
Death by chaperone: HSP90, HSP70 or both? Cell Cycle (2009) 1.22
Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection. Cell (2015) 1.20
Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90. Chem Biol (2010) 1.09
Dengue virus. Clin Lab Med (2010) 1.07
Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus. Virol J (2010) 1.05
Analysis of protein interactions in situ by proximity ligation assays. Curr Top Microbiol Immunol (2014) 1.01
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib. Mol Cancer Ther (2009) 0.98
HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer. Oncogene (2013) 0.94
The purinome, a complex mix of drug and toxicity targets. Curr Top Med Chem (2006) 0.93
Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets. Bioorg Med Chem Lett (2013) 0.91
The growth transformation of human B cells involves superinduction of hsp70 and hsp90. Virology (1993) 0.90
Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancer. Mol Cancer Ther (2013) 0.89
Heat shock effect upon dengue virus replication into U937 cells. Virus Res (2008) 0.89
Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70. Chem Biol (2014) 0.88
Fluorescence linked enzyme chemoproteomic strategy for discovery of a potent and selective DAPK1 and ZIPK inhibitor. ACS Chem Biol (2013) 0.87
Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection. Microbes Infect (2006) 0.87
A highly selective Hsp90 affinity chromatography resin with a cleavable linker. Bioorg Med Chem (2012) 0.86
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells. Chem Biol (2013) 0.84
Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection. Infect Dis Obstet Gynecol (1999) 0.84
Measuring plasma membrane protein endocytic rates by reversible biotinylation. J Vis Exp (2009) 0.82
Surface proteins of C6/36 cells involved in dengue virus 4 binding and entry. Arch Virol (2013) 0.79
Dengue virus infection activates cellular chaperone Hsp70 in THP-1 cells: downregulation of Hsp70 by siRNA revealed decreased viral replication. Viral Immunol (2010) 0.79
Increased expression of 70 kD heat shock protein in cultured primary human keratinocytes induced by human papillomavirus 16 E6/E7 gene. Chin Med J (Engl) (2005) 0.77